David practices in the firm's Private Equity Practice, representing mid-market private equity sponsors, strategic investors, and family offices in the structuring and negotiation of leveraged buyouts, mergers, acquisitions, divestitures, and minority investments across multiple industries. David also advises private equity clients and their portfolio companies on contractual and commercial matters, legal due diligence, corporate governance, restructuring, and corporate advisory issues.
Prior to joining Mintz, David was an associate in the global transactions practice of an international law firm in New York City and the private equity practice of a multinational law firm based in Australia. During his tenure at these firms, he was the lead transaction and corporate governance associate for multiple mid-market and private equity platforms.
David is a visiting lecturer at Harvard Law School and a member of the 2024 Boston Future Leaders Program 2024 Boston's Future Leaders Program, which is a 10-month leadership initiative by Harvard Business School and the Greater Boston Chamber of Commerce.
Not admitted to practice in Massachusetts. Admitted to practice only in the State of New York and New South Wales, Australia.
Experience
- Represented Artemis in multiple transactions, including its acquisition of Diamond Antenna and Microwave Corporation, a developer of advanced radio frequency and electro-mechanical solutions for mission-critical applications at the frontier of national security, connectivity, and mobility; its acquisition of SightLine Applications, LLC, a developer of image processing electronics and software products; its acquisition of Tekscan, Inc., a manufacturer of flexible, ultra-thin sensors and systems; its acquisition of McDanel Advanced Ceramic Technologies, LLC, a manufacturer of high-quality industrial and advanced technical ceramics and McDanel's add-on acquisition of Ravotek, a specialty manufacturer of high-performing optical window and mirror systems.
- Represented Monomoy Capital Partners in connection with its acquisition of Cast-Crete Holdings, LLC, the nation's largest manufacturer and distributor of precast and prestressed concrete lintels and sills.
- Represented Charlesbank Capital Partners in a leveraged buyout of Healthcare Fraud Shield, a SaaS-based software manufacturer.
- Represented DW Healthcare Partners in selling Med-Pharmex, a veterinary pharmaceutical manufacturer.
- Represented Invited, Inc., an Apollo portfolio company, in connection with multiple divestitures, including the sale of the BigShots Golf business to TopGolf Callaway Brands Corp. and the sale of the Stadium Clubs business to Oak View Group.
- Represented Berenson Capital Partners in its leveraged buyout of Interactive Digital Solutions and MedSitter.
- Represented LucyRx in its acquisition of a pharmaceutical benefit manager.
- Represented Ferra Holdings Limited, a leading global provider of highly engineered, complex, and advanced components, subsystems, and assemblies for the military aerospace and commercial aerospace end markets, on its sale to Accurus Aerospace Corporation, a portfolio company of Liberty Hall Capital Partners.
- Represented Sabatino North America, LLC and Sabatino Italia, related companies involved in the farming, manufacturing, distribution, and sale of truffles and truffle-based products (e.g., truffle salt; truffle oil) to private equity sponsor Traub Capital Partners.
- Represented Capstone Partners, an investment banking and advisory firm serving middle-market companies, in its sale to Huntington Bancshares Incorporated (NASDAQ: HBAN).
viewpoints
Restrictive Covenants in Private Equity Transactions
May 14, 2025 | Alert | By Garrett Galvin, David G. Conway, Katya Daniel, Benjamin Ferrucci, Tom J. Pagliarini
Restrictive covenants are unquestionably a significant deal consideration in M&A transactions. In the private equity context, a buyer is focused on restrictive covenants to protect its investment by binding the sellers and other recipients of material deal proceeds to obligations and restrictions for a certain period of time following the transaction. Restrictive covenants serve several purposes and are highly beneficial for a buyer; accordingly, absent any legal limitations and assuming sufficient consideration, a buyer is incentivized to impose restrictive covenants on as many selling parties as possible. However, and not surprisingly, sellers heavily negotiate their post-transaction restrictive covenant obligations to keep their business options as open as possible on a go-forward basis. The conflicting interests of buyers and sellers when it comes to restrictive covenants result in carefully negotiated covenants spread out over multiple transaction documents and employment agreements. This article discusses the common restrictive covenants used in private equity transactions, the importance of such covenants in the key transaction documents, and related enforcement considerations.
COVID-19 and Poison Pills: The Right Prescription?
April 30, 2020 | Advisory | By Matthew Gardella, Scott M. Stanton, David G. Conway
News & Press
Mintz Advises SightLine on its Acquisition of Athena AI
March 12, 2025|
Mintz Advises Artemis on Acquisition of Richland Glass Company
January 16, 2025|
Mintz Announces New Members
December 20, 2024|
Twenty-nine Mintz Attorneys Named to 2023 New York Metro Super Lawyers List
September 22, 2023
NEW YORK – Mintz is pleased to announce that 18 attorneys have been named New York Metro Super Lawyers and 11 attorneys have been named New York Metro Rising Stars by Super Lawyers for 2023.
Mintz Leads On A Quartet of Back-To-Back Private Equity Closings
October 25, 2022|
Mintz Represents Ferra Holdings In Its Sale To Accurus
April 11, 2022|
Events & Speaking
Visiting Lecturer, Transactional Law Workshop – Mergers and Acquisitions, Harvard Law School (February 2026)
Harvard Law School
Visiting Lecturer, Transactional Law Workshop – Mergers and Acquisitions, Harvard Law School (January 2024)
Harvard Law School
Recognition & Awards
New York Super Lawyers: Rising Stars – Corporate (2023)
Recent Insights
Restrictive Covenants in Private Equity Transactions
May 14, 2025| Alert
